Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays.

Two strategies are described for detecting constitutive or induced protein-protein interactions in intact mammalian cells; these strategies are based on oligomerization domain-assisted complementation of rationally designed fragments of the murine enzyme dihydrofolate reductase (DHFR; EC 1.5.1.3). We describe a dominant clonal-selection assay of stably transfected cells expressing partner proteins FKBP (FK506 binding protein) and FRAP (FKBP-rapamycin binding protein) fused to DHFR fragments and show a rapamycin dose-dependent survival of clones that requires approximately 25 molecules of reconstituted DHFR per cell. A fluorescence assay also is described, based on stoichiometric binding of fluorescein-methotrexate to reconstituted DHFR in vivo. Formation of the FKBP-rapamycin-FRAP complex is detected in stably and transiently transfected cells. Quantitative rapamycin dose-dependence of this complex is shown to be consistent with in vitro binding and distinguishable from a known constitutive interaction of FKBP and FRAP. We also show that this strategy can be applied to study membrane protein receptors, demonstrating dose-dependent activation of the erythropoietin receptor by ligands. The combination of these clonal-selection and fluorescence assays in intact mammalian cells makes possible selection by simple survival, flow cytometry, or both. High-throughput drug screening and quantitative analysis of induction or disruption of protein-protein interactions are also made possible.

[1]  J. Zhang,et al.  A yeast three-hybrid method to clone ternary protein complex components. , 1996, Analytical biochemistry.

[2]  R. Perham,et al.  Self-assembly of biological macromolecules. , 1975, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[3]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[4]  S. Schreiber,et al.  Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Blau,et al.  Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Lodish,et al.  Expression cloning of the murine erythropoietin receptor , 1989, Cell.

[7]  Jan E. Schnitzer,et al.  Role of GTP Hydrolysis in Fission of Caveolae Directly from Plasma Membranes , 1996, Science.

[8]  Stuart L. Schreiber,et al.  Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP , 1996, Science.

[9]  M. Kozak,et al.  Regulation of translation in eukaryotic systems. , 1992, Annual review of cell biology.

[10]  V. Pathak,et al.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs , 1989, Molecular and cellular biology.

[11]  S. Michnick,et al.  Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Schreiber,et al.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Chasin,et al.  Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[15]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[16]  F. M. Huennekens,et al.  Synthesis of a fluorescent derivative of amethopterin,. , 1975, Journal of medicinal chemistry.

[17]  M. Wickens,et al.  A three-hybrid system to detect RNA-protein interactions in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[19]  L S Mulcahy,et al.  Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. , 1998, Biochemistry.

[20]  A. George,et al.  Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targeting. , 1997, Protein Engineering.

[21]  Raymond L. Blakley,et al.  Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. , 1988, The Journal of biological chemistry.

[22]  R. Pictet,et al.  Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim. , 1988, The Journal of biological chemistry.

[23]  J. Bertino,et al.  Regulation of dihydrofolate reductase and other folate-requiring enzymes. , 1968, Advances in enzyme regulation.

[24]  J. Bertino,et al.  Quantitation of dihydrofolate reductase in individual parental and methotrexate-resistant murine cells. Use of a fluorescence activated cell sorter. , 1978, The Journal of biological chemistry.

[25]  D. Ladant,et al.  A bacterial two-hybrid system based on a reconstituted signal transduction pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Varshavsky,et al.  Split ubiquitin as a sensor of protein interactions in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Andrzej Galat,et al.  Molecular cloning and overexpression of the human FK506-binding protein FKBP , 1990, Nature.

[28]  J. Heitman,et al.  FKBP12‐rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol‐4 kinase activity. , 1995, The EMBO journal.

[29]  E J Licitra,et al.  A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Kaufman,et al.  Dexamethasone negatively regulates the activity of a chimeric dihydrofolate reductase/glucocorticoid receptor protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.